about
Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersDetecting BRCA2 protein truncation in tissue biopsies to identify breast cancers that arise in BRCA2 gene mutation carriers.Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Regarding the use of tamoxifen post-oophorectomy to prevent hereditary breast cancer.Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial.Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models.Personalized medicine: a personal viewRegular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous studyPrevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing.Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish populationBRCA1 is required for postreplication repair after UV-induced DNA damageEducational needs about cancer family history and genetic counseling for cancer risk among frontline healthcare clinicians in New York CityOverview of the development of personalized genomic medicine and surgeryFunctional assays for BRCA1 and BRCA2.Bilateral male breast cancer with male potential hypogonadism.Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriersAKT regulates BRCA1 stability in response to hormone signaling.Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study.Mechanisms of BRCA1 tumor suppressionFactors increasing local recurrence in breast-conserving surgery.Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriersComplementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancerManagement of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.Management options after prophylactic surgeries in women with BRCA mutations: a review.Cancer risk assessment and the genetic counseling process: using hereditary breast and ovarian cancer as an example.BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy.A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencingAnalysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal womenPreclinical mouse models for BRCA1-associated breast cancer.Identification, Evaluation, and Treatment of Patients with Hereditary Cancer Risk within the United States.Management of oral and gastrointestinal mucositis: ESMO clinical recommendations.BRCA sequencing and large rearrangement testing in young Black women with breast cancer.Studying therapy response and resistance in mouse models for BRCA1-deficient breast cancer.Gene expression abnormalities in histologically normal breast epithelium from patients with luminal type of breast cancer.Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.
P2860
Q24813705-BFC1E74D-D6C9-4FB1-B5B4-24F804F92D70Q33561582-8494D569-B8AE-4894-BCE8-0464873CDC7FQ33564013-341552DB-FD32-42FE-BE8D-E0920B6E8821Q33722573-3E005CD9-5B48-4EB0-ACBB-D0EB6676FDCAQ33789533-6A018FBD-96EA-468E-A7D6-149536BF6EB6Q34102617-13530341-DF28-4844-A92E-160CC37DBAA9Q34171954-2750E749-EDC9-4311-A59B-7545195466A0Q34306492-33DF0637-0FAA-43DC-B768-15645E301C47Q34311315-9B6EFA21-DCB8-491F-AB99-45E57F8CDCAEQ34421019-0C3EA086-2611-427D-8889-DBF17C448048Q34574542-A125C92E-4A84-4AED-AA58-0063F3E143B7Q35434721-FE07936E-3A59-4835-B5E7-E5941C3E8A89Q35486234-01740A6A-582D-4E9B-B8E0-8FEFB920B105Q35763328-BE38687F-122A-4E17-9A95-3C43ADFBCCD8Q35775886-952231C5-00AC-4422-835C-2D8DC589164FQ35843736-3FF4FFFC-79CA-43AC-8094-93DCA4174B35Q35854671-A3A4712D-4BBB-4E5C-98EC-36F62D82D79FQ35900421-0C3C46A4-29D0-43DA-82AB-42EAE26CD7BCQ35994422-D6BDFD76-BD9B-4D1B-9BCD-2110E1E2B36EQ36070055-F558D93E-B5AB-4711-A16F-FE90471DBD18Q36219554-3A241086-328C-4BE4-81E1-CBC04350727DQ36235597-F650AD8F-C975-4244-B199-D6DC158CBF93Q36359653-F06BA09F-3969-486D-96D7-0D83965069CBQ36610563-80DD8401-EA76-4203-9FF3-B15B9FA4FADAQ36667556-4A3D3A22-7C38-47BF-8B38-2AC7B02D23BFQ36870783-0543CB0B-D983-40B1-9F8C-C6E736B9218FQ36959824-F22023E6-F22B-4EAA-95D7-489AE63E45CEQ37137241-69037A6F-D97A-4E76-BFFF-D376F56450BFQ37157563-035088E8-3BB0-4F2F-A98B-60754F21C331Q37164443-14F63A06-FC51-4F0B-B5E1-C5463A982C69Q37193409-CD6C0821-171B-4486-A6A4-A86AEF9AD9BCQ37355998-2DF961BA-60FE-4803-AACC-76BF05C2372FQ37424070-F5596BF5-3F27-488C-B2D6-93B1597B22ABQ37450153-E1818ADC-A23F-495E-A26E-9C547FAE904EQ37489063-21A24A4D-E8B1-4F81-8280-49C09F449880Q37639406-77B72706-3699-4C86-A0AB-9091D8DBCE96Q37844487-6532BE4E-3EB6-4EDB-AB90-8EA2CC61D6DDQ38470401-F6382B24-7893-4967-9191-4D24A4EDA703Q38759417-AAF32353-CC2A-4226-A724-F39B64A97396Q39637429-A3F1D52C-BD3E-4EBF-B686-BCE96A494F5B
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Prevention and management of hereditary breast cancer.
@ast
Prevention and management of hereditary breast cancer.
@en
type
label
Prevention and management of hereditary breast cancer.
@ast
Prevention and management of hereditary breast cancer.
@en
prefLabel
Prevention and management of hereditary breast cancer.
@ast
Prevention and management of hereditary breast cancer.
@en
P356
P1476
Prevention and management of hereditary breast cancer.
@en
P304
P356
10.1200/JCO.2005.10.035
P407
P577
2005-03-01T00:00:00Z